Showing results (291-300 of 444) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|December 15, 2015
MiR-138 exerts anti-glioma efficacy by targeting immune checkpointsJun Wei, Edjah K Nduom, Ling-Yuan Kong, et al.Neuro-Oncology Advances|March 5, 2025
ICAM-1 and IL-10 are associated with cognitive dysfunction using the MoCA test in glioma: Findings from the NCI Neuro-Oncology Branch Natural History StudyKaitlynn Slattery, McKenzie C Kauss, Dhaivat Raval, et al.The Oncologist|February 17, 2021
Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable ChordomaPeter Joseph DeMaria, Marijo Bilusic, Deric M Park, et al.Neuro-Oncology|July 6, 2019
Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastomaJing Cui, Qi Zhang, Qi Song, et al.Neuro-Oncology Practice|June 9, 2025
Implications of sociodemographic and clinical factors on symptom burden: Age-specific survivorship care in the primary central nervous system tumor populationKimberly R Robins, Tricia Kunst, Jennifer Reyes, et al.Neuro-Oncology Advances|October 2, 2023
The sex-dependent impact of PER2 polymorphism on sleep and activity in a novel mouse model of cranial-irradiation-induced hypersomnolenceKendra A Adegbesan, Francesco Tomassoni Ardori, Sudhirkumar Yanpallewar, et al.Frontiers in Oncology|August 2, 2021
Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS MalignanciesNivedita M Ratnam, Heather M Sonnemann, Stephen C Frederico, et al.Neuro-Oncology Advances|January 31, 2024
TGF-β and BMP signaling are associated with the transformation of glioblastoma to gliosarcoma and then osteosarcomaAiguo Li, John C Hancock, Martha Quezado, et al.Neuro-Oncology Advances|July 10, 2020
NCI-CONNECT: Comprehensive Oncology Network Evaluating Rare CNS Tumors-Histone Mutated Midline Glioma Workshop ProceedingsBrett J Theeler, Yamini Dalal, Michelle Monje, et al.Neuro-Oncology|August 30, 2024
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomasFelix Sahm, Kenneth D Aldape, Priscilla K Brastianos, et al.Pageof 45